XPH Looks Tempting, but the Five-Year Chart Warns Investors
SPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
A solid budget helps young professionals manage irregular income and set aside funds for future goals.
19,978 articlesSPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
Healthcare REITs offer income, but they carry unique risks. Learn how to evaluate Medical Properties Trust with actio...
Geopolitical risk in the Middle East is reshaping energy markets. Five high-yield energy stocks offer robust dividend...
February brought a sharp setback for C3.ai investors. This article explains why shares C3.ai stock fell, what it mean...
Thinking about a 20-year horizon? Here are two high-quality picks I’d stake my plan on, with clear reasons, real-worl...
CrowdStrike stock absolutely hammered this week, yet the dip isn’t a clear buy signal. I break down the risks, the gr...
A leading wealth manager launches a new regional bank holding with $4.5 million in seed capital. Explore what this me...
What would it take for the next company to reach a $5 trillion market cap? This article breaks down the path, the can...
Over the last year, ISCV outpaced IJJ, but market cycles can change on a dime. This guide explains why that edge may ...
Healthcare fraud hits your wallet. This piece explains a real case where a lab owner allegedly billed Medicaid for te...
Investors chase the next big energy winner as AI drives data centers demand. Oklo presents a high-risk, high-puture o...
Two former governors unveil a bipartisan coalition designed to prepare America’s workforce for an AI-driven future, w...